Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common Stock and Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Non-controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2023		167.4
Balance at beginning of period at Dec. 31, 2023		$ 1,624	$ (2,540)	$ 1,640	$ 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings				(39)	1
Other comprehensive income (loss)			(13)
Issuance of common stock and stock options exercised (in shares)		1.0
Issuance of common stock and stock options exercised		$ (5)
Share repurchase program (in shares)		(0.1)
Share repurchase program				(39)
Share-based compensation expenses		$ 56
Dividends declared				(163)
Balance at ending of period (in shares) at Mar. 30, 2024		168.3
Balance at end of period at Mar. 30, 2024		$ 1,675	(2,553)	1,399	16
Balance at beginning of period (in shares) at Dec. 31, 2023		167.4
Balance at beginning of period at Dec. 31, 2023		$ 1,624	(2,540)	1,640	15
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	$ 970
Other comprehensive income (loss)	70
Balance at ending of period (in shares) at Sep. 28, 2024		168.4
Balance at end of period at Sep. 28, 2024		$ 1,822	(2,470)	1,974	15
Balance at beginning of period (in shares) at Mar. 30, 2024		168.3
Balance at beginning of period at Mar. 30, 2024		$ 1,675	(2,553)	1,399	16
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings				443	2
Other comprehensive income (loss)			4
Issuance of common stock and stock options exercised (in shares)		0.1
Issuance of common stock and stock options exercised		$ 6
Share repurchase program (in shares)		(0.2)
Share repurchase program				(71)
Share-based compensation expenses		$ 63
Dividends declared				(164)
Dividends paid to non-controlling interest on subsidiary common stock					(3)
Balance at ending of period (in shares) at Jun. 29, 2024		168.2
Balance at end of period at Jun. 29, 2024		$ 1,744	(2,549)	1,607	15
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	563			562	1
Other comprehensive income (loss)	79		79
Issuance of common stock and stock options exercised (in shares)		0.3
Issuance of common stock and stock options exercised		$ 17
Share repurchase program (in shares)		(0.1)
Share repurchase program				(31)
Share-based compensation expenses		$ 61
Dividends declared				(164)
Dividends paid to non-controlling interest on subsidiary common stock					(1)
Balance at ending of period (in shares) at Sep. 28, 2024		168.4
Balance at end of period at Sep. 28, 2024		$ 1,822	(2,470)	1,974	15
Balance at beginning of period (in shares) at Dec. 31, 2024		168.6
Balance at beginning of period at Dec. 31, 2024	1,719	$ 1,942	(2,539)	2,300	16
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings				430	2
Other comprehensive income (loss)			39
Issuance of common stock and stock options exercised (in shares)		0.7
Issuance of common stock and stock options exercised		$ (90)
Share repurchase program (in shares)		(0.7)
Share repurchase program				(325)
Share-based compensation expenses		$ 66
Dividends declared				(182)
Balance at ending of period (in shares) at Mar. 29, 2025		168.6
Balance at end of period at Mar. 29, 2025		$ 1,918	(2,500)	2,223	18
Balance at beginning of period (in shares) at Dec. 31, 2024		168.6
Balance at beginning of period at Dec. 31, 2024	1,719	$ 1,942	(2,539)	2,300	16
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	1,510
Other comprehensive income (loss)	$ 122
Share repurchase program (in shares)	(1.5)
Share repurchase program	$ (664)
Balance at ending of period (in shares) at Sep. 27, 2025		168.4
Balance at end of period at Sep. 27, 2025	2,344	$ 2,150	(2,417)	2,594	17
Balance at beginning of period (in shares) at Mar. 29, 2025		168.6
Balance at beginning of period at Mar. 29, 2025		$ 1,918	(2,500)	2,223	18
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings				513	2
Other comprehensive income (loss)			88
Issuance of common stock and stock options exercised (in shares)		0.3
Issuance of common stock and stock options exercised		$ 53
Share repurchase program (in shares)		(0.6)
Share repurchase program				(219)
Share-based compensation expenses		$ 74
Dividends declared				(182)
Dividends paid to non-controlling interest on subsidiary common stock					(4)
Balance at ending of period (in shares) at Jun. 28, 2025		168.3
Balance at end of period at Jun. 28, 2025		$ 2,045	(2,412)	2,335	16
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	564			562	2
Other comprehensive income (loss)	$ (5)		(5)
Issuance of common stock and stock options exercised (in shares)		0.4
Issuance of common stock and stock options exercised		$ 32
Share repurchase program (in shares)	(0.3)	(0.3)
Share repurchase program	$ (121)			(121)
Share-based compensation expenses		$ 73
Dividends declared				(182)
Dividends paid to non-controlling interest on subsidiary common stock					(1)
Balance at ending of period (in shares) at Sep. 27, 2025		168.4
Balance at end of period at Sep. 27, 2025	$ 2,344	$ 2,150	$ (2,417)	$ 2,594	$ 17